SMIN:LSESmiths Group Plc Analysis
Data as of 2026-05-28 - not real-time
£2,455.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Smiths Group trades at 2,455 GBp, sitting just below its 20‑day (2,502 GBp) and 50‑day (2,456 GBp) moving averages, with a neutral RSI of 44 and a bearish MACD histogram, indicating short‑term pressure near the 2,405 GBp support level. The stock’s trailing P/E of 33× is above the industry average of 30×, while the forward P/E of 20× suggests modest earnings improvement ahead. A DCF‑derived fair value of roughly 850 GBp places the market price well above intrinsic estimates, reinforcing an overvalued bias despite a 13 % upside estimate from other models. Recent guidance cuts – organic revenue growth now seen at ~2% after Middle‑East disruptions to John Crane – further temper optimism.
On the fundamentals side, Smiths delivers a 1.88 % dividend yielding 62 % payout, supported by positive operating cash flow and a moderate debt‑to‑equity of 73 %. The company’s diversified portfolio across detection, sealing and interconnect technologies provides resilience, and the forward earnings outlook (EPS ~ 1.19) offers a potential earnings multiple contraction. The stable dividend and low beta also make the stock appealing for income‑focused investors. With a beta of 0.6 and stable trading volumes, volatility risk is limited, though the negative free cash flow and elevated leverage warrant caution. However, the sizable debt load and recent cash flow shortfall suggest monitoring liquidity closely. Overall, the balance of modest growth prospects, attractive yield and sector positioning supports a buy view for medium‑ to long‑term horizons, while short‑term positioning remains defensive.
On the fundamentals side, Smiths delivers a 1.88 % dividend yielding 62 % payout, supported by positive operating cash flow and a moderate debt‑to‑equity of 73 %. The company’s diversified portfolio across detection, sealing and interconnect technologies provides resilience, and the forward earnings outlook (EPS ~ 1.19) offers a potential earnings multiple contraction. The stable dividend and low beta also make the stock appealing for income‑focused investors. With a beta of 0.6 and stable trading volumes, volatility risk is limited, though the negative free cash flow and elevated leverage warrant caution. However, the sizable debt load and recent cash flow shortfall suggest monitoring liquidity closely. Overall, the balance of modest growth prospects, attractive yield and sector positioning supports a buy view for medium‑ to long‑term horizons, while short‑term positioning remains defensive.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below short‑term moving averages and near support
- Bearish MACD and neutral RSI indicating limited upside
- Recent revenue outlook cut and Middle‑East disruption
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward P/E compression to ~20×
- Attractive dividend yield with sustainable payout
- Low beta and stable trading volumes reducing volatility risk
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Diversified segment exposure (Detection, John Crane, Flex‑Tek, Interconnect)
- Consistent dividend and income appeal
- Strategic portfolio repositioning and long‑term contracts supporting growth
Key Metrics & Analysis
Financial Health
Revenue Growth-1.00%
Profit Margin8.71%
P/E Ratio33.2
ROE12.53%
ROA6.54%
Debt/Equity73.09
P/B Ratio4.8
Op. Cash Flow£374.0M
Free Cash Flow£-778750016
Industry P/E30.0
Technical Analysis
TrendNeutral
RSI44.2
Support£2,405.00
Resistance£2,640.00
MA 20£2,502.40
MA 50£2,456.28
MA 200£2,457.81
MACDBearish
VolumeStable
Fear & Greed Index92.52
Valuation
Fair Value£849.97
Target Price£2,790.00
Upside/Downside13.65%
GradeOvervalued
TypeBlend
Dividend Yield1.88%
Risk Assessment
Beta0.60
Volatility21.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.